Episode

Histotripsy: Changing How We Treat Cancer

Podcast
the goop podcast
Published
Feb 17, 2026
Duration seconds
3138
Processing state
not_requested
Canonical source
https://pdst.fm/e/traffic.megaphone.fm/CAD2261391529.mp3?updated=1771955006
Audio
https://pdst.fm/e/traffic.megaphone.fm/CAD2261391529.mp3?updated=1771955006
JSON
/v1/public/podcasts/the-goop-podcast-490260/episodes/histotripsy-changing-how-we-treat-cancer
Markdown
/podcast/the-goop-podcast-490260/histotripsy-changing-how-we-treat-cancer.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-goop-podcast-490260/episodes/histotripsy-changing-how-we-treat-cancer/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-goop-podcast-490260/histotripsy-changing-how-we-treat-cancer.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Gwyneth sits down with Mike Blue—CEO of HistoSonics—to explore histotripsy, a breakthrough noninvasive ultrasound technology designed to destroy tumors without surgery, chemotherapy, or radiation. He shares the 25-year journey behind the technology, the patients already benefiting from the FDA-cleared treatment for liver tumors, and how this approach could challenge decades of invasive cancer care—signaling a profound shift toward safer, more precise treatment. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices